Dr. Sujie Tang, MD

Dr. Tang practices at Sunrise Surgical Center Mirabadi Parvin Gen PTR in Sherman Oaks, California.

Dr. Tang's NPI, 1134302409, was assigned on December 10, 2007. Dr. Tang graduated from Shandong Medical University in 1994. Dr. Tang holds California license A107300.

Dr. Tang's primary practice is Sunrise Surgical Center Mirabadi Parvin Gen PTR, at 4940 N Van Nuys Blvd, Sherman Oaks, CA 91403 in Los Angeles County. The practice phone is (818) 782-0004.

Dr. Tang's primary practice is Sunrise Surgical Center Mirabadi Parvin Gen PTR in Sherman Oaks, California. Dr. Tang is also affiliated with Sherman Oaks Hospital. Dmand AI also links Dr. Tang to 4 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tang practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tang is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Tang's licenses on file in 2 states: California and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Tang treats.

CMS data shows 14,230 Medicare services from Dr. Tang across 20 procedure codes in 2024, for 410 Medicare patients. Medicare paid $434,572 for them.

CMS counts 410 Medicare patients who saw Dr. Tang in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 75% are also on Medicaid. Their average risk score is 3.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tang's median patient age at 64, with 54% women.

In 2024, Dr. Tang wrote 771 Medicare Part D claims for 84 patients. 45% of them were for generic drugs. CMS names the drug for 484 of them, across 25 drugs with 11 or more claims each, at $2,760,042 in total drug cost. In 2023, CMS named 554 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tang for performance year 2024, reported individually. Dr. Tang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tang as offering telehealth.

Dmand AI links 1 paper to Dr. Tang. Dr. Tang's most frequent co-author is Michael R. Debaun, MD.

CMS Open Payments shows 605 general payments to Dr. Tang from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Bristol-Myers Squibb Company paid the most, $1,685.

Dmand AI lists 1 award for Dr. Tang, most recently Fellow Research Award - Medical Oncology in 2012.

Dr. Tang graduated from Shandong Medical University in 1994. Dr. Tang is a member of ACP and ASCO.

Dr. Tang is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.